Home » Topics » Regulatory

Regulatory
RSS

IVIg for acute cardiomyopathy

June 9, 1997

Generic aciclovir approved by FDA

June 9, 1997

Aciclovir demonstrates antiasthmatic activity in animal model

June 9, 1997

First approval for new MRI contrast agent from Nycomed

June 6, 1997

FDA approves generic version of Diamox

June 6, 1997

Oculex and Storz sign marketing agreement for ocular product

June 5, 1997

Didronel PMO approved for prevention of osteoporosis in U.K.

June 5, 1997

New i.v. formulation of amiodarone better tolerated in patients

June 2, 1997

Wyeth-Ayerst's Normiflo approved for prevention of deep vein thrombosis

June 2, 1997

DuPont Merck receives FDA approval for nuclear imaging breast cancer test

May 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...